|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: CONDUCTUS INC, 10-Q, EX-10.4, 2000-08-14 |
Next: WATSON PHARMACEUTICALS INC, 10-Q, 2000-08-14 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> APR-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 22,562
<SECURITIES> 0
<RECEIVABLES> 303
<ALLOWANCES> 0
<INVENTORY> 2,893
<CURRENT-ASSETS> 25,902
<PP&E> 10,079
<DEPRECIATION> 8,496
<TOTAL-ASSETS> 27,696
<CURRENT-LIABILITIES> 3,428
<BONDS> 0
0
0
<COMMON> 2
<OTHER-SE> 0
<TOTAL-LIABILITY-AND-EQUITY> 27,696
<SALES> 0
<TOTAL-REVENUES> 237
<CGS> 0
<TOTAL-COSTS> 4,079
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 57
<INCOME-PRETAX> (3,443)
<INCOME-TAX> 1
<INCOME-CONTINUING> (3,444)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (3,444)
<EPS-BASIC> (.70)
<EPS-DILUTED> (.70)
</TABLE>
|
|